Importantly, we demonstrated mitochondrial dysfunction as a critical mechanism underlying SORD deficiency–induced neuropathy, evidenced by increased ROS levels, increased levels of apoptosis, compromised ATP production, and the decreased intensity of mitochondrial marker TOM20. The gene discussed is TOMM20; the disease is neuropathy.